Monotherapy
Drug | Drug Name | Drug Description |
---|---|---|
DB01238 | Aripiprazole | An atypical antipsychotic used in the treatment of a wide variety of mood and psychotic disorders, such as schizophrenia, bipolar I, major depressive disorder, irritability associated with autism, and Tourette's syndrome. |
DB09038 | Empagliflozin | An SGLT2 inhibitor used to manage type 2 diabetes mellitus. |
DB05889 | Inotuzumab ozogamicin | An antibody-drug conjugate used to treat B-cell precursor acute lymphoblastic leukemia (ALL). |
DB00762 | Irinotecan | A topoisomerase inhibitor used to treat metastatic carcinoma of the colon or rectum and pancreatic adenocarcinoma. |
DB00108 | Natalizumab | A monoclonal anti-integrin antibody used to treat Crohn's disease or multiple sclerosis. |
DB00776 | Oxcarbazepine | An anti-epileptic used in the treatment of partial-onset seizures. |
DB00642 | Pemetrexed | A folate analog used to treat mesothelioma and non-small cell lung cancer. |
DB15626 | Spesolimab | An interleukin-36 receptor antagonist used to treat generalized pustular psoriasis flares in adults. |
DB16732 | Tisotumab vedotin | A tissue factor-directed antibody drug conjugate that is used to treat adults with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. |
DB06273 | Tocilizumab | An interleukin-6 (IL-6) receptor antagonist used to treat Cytokine Release Syndrome (CRS), Systemic Juvenile Idiopathic Arthritis (sJIA), Giant Cell Arteritis (GCA), and Rheumatoid Arthritis (RA). |
DB00361 | Vinorelbine | A vinca alkaloid used in the treatment of metastatic non-small cell lung carcinoma (NSLC) and in conjunction with other drugs in locally advanced NSCLC. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB07101 | Mirdametinib | 1 / 2 | Recruiting | 1 |
DB08930 | Dolutegravir | 2 | Completed | 1 |
DB08930 | Dolutegravir | 2 | Unknown Status | 1 |
DB00564 | Carbamazepine | 3 | Completed | 2 |
DB06218 | Lacosamide | 3 | Completed | 2 |